Chen‐Kan Tseng

2.4k total citations
78 papers, 1.7k citations indexed

About

Chen‐Kan Tseng is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chen‐Kan Tseng has authored 78 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 37 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Chen‐Kan Tseng's work include Esophageal Cancer Research and Treatment (29 papers), Esophageal and GI Pathology (23 papers) and Gastric Cancer Management and Outcomes (21 papers). Chen‐Kan Tseng is often cited by papers focused on Esophageal Cancer Research and Treatment (29 papers), Esophageal and GI Pathology (23 papers) and Gastric Cancer Management and Outcomes (21 papers). Chen‐Kan Tseng collaborates with scholars based in Taiwan, United States and Malaysia. Chen‐Kan Tseng's co-authors include Hsien‐Kun Chang, Yin‐Kai Chao, Chi‐Cheng Chuang, Yun‐Hen Liu, Ping‐Ching Pai, Ngan‐Ming Tsang, Ya-Lan Sun, Will Wei-Cheng Chiu, Chi‐Ju Yeh and Kuo‐Chen Wei and has published in prestigious journals such as Cancer, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Chen‐Kan Tseng

78 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen‐Kan Tseng Taiwan 22 694 574 441 265 244 78 1.7k
Naoto Shikama Japan 22 626 0.9× 504 0.9× 479 1.1× 137 0.5× 212 0.9× 156 1.7k
Pramod Kumar Julka India 22 411 0.6× 478 0.8× 326 0.7× 227 0.9× 92 0.4× 124 1.6k
Ferah Yıldız Türkiye 20 448 0.6× 376 0.7× 348 0.8× 163 0.6× 288 1.2× 123 1.3k
Enis Özyar Türkiye 23 575 0.8× 546 1.0× 575 1.3× 161 0.6× 579 2.4× 117 1.7k
Yavuz Anacak Türkiye 19 318 0.5× 262 0.5× 332 0.8× 178 0.7× 98 0.4× 57 1.1k
H. Marsiglia France 23 531 0.8× 629 1.1× 908 2.1× 143 0.5× 82 0.3× 113 2.2k
Robert H. Sagerman United States 25 696 1.0× 682 1.2× 456 1.0× 275 1.0× 180 0.7× 82 1.9k
Supriya Mallick India 22 303 0.4× 502 0.9× 505 1.1× 180 0.7× 188 0.8× 121 1.6k
Giampaolo Biti Italy 22 237 0.3× 604 1.1× 449 1.0× 127 0.5× 143 0.6× 88 1.4k
Gökhan Özyiğit Türkiye 22 853 1.2× 1.0k 1.8× 402 0.9× 156 0.6× 1.0k 4.2× 133 2.3k

Countries citing papers authored by Chen‐Kan Tseng

Since Specialization
Citations

This map shows the geographic impact of Chen‐Kan Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Kan Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Kan Tseng more than expected).

Fields of papers citing papers by Chen‐Kan Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Kan Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Kan Tseng. The network helps show where Chen‐Kan Tseng may publish in the future.

Co-authorship network of co-authors of Chen‐Kan Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Kan Tseng. A scholar is included among the top collaborators of Chen‐Kan Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Kan Tseng. Chen‐Kan Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Ming‐Mo, et al.. (2024). Temporal Trends in Survival Outcomes for Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy: A 14-Year Analysis. Annals of Surgical Oncology. 31(10). 6652–6661. 4 indexed citations
2.
Chen, Ko‐Ting, Chiung-Yin Huang, Ping‐Ching Pai, et al.. (2023). Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study. Journal of Neuro-Oncology. 165(3). 535–545. 20 indexed citations
3.
Hsueh, William, Kun‐Yun Yeh, Yu‐Shin Hung, et al.. (2022). Albumin and Neutrophil-to-Lymphocyte Ratio Score in Neoadjuvant Concurrent Chemoradiotherapy for Esophageal Cancer: Comparison With Prognostic Nutritional Index. In Vivo. 36(5). 2400–2408. 7 indexed citations
4.
Huang, Yung‐Hsin, Yu‐Shin Hung, Cheng-Chou Lai, et al.. (2021). Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy. Anticancer Research. 41(10). 5213–5222. 6 indexed citations
5.
Wei, Kuo‐Chen, Peng‐Wei Hsu, Hong‐Chieh Tsai, et al.. (2021). Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study. Scientific Reports. 11(1). 24067–24067. 7 indexed citations
6.
Wen, Yu‐Wen, et al.. (2017). Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy. Journal of Thoracic and Cardiovascular Surgery. 155(5). 2233–2242.e2. 3 indexed citations
7.
Su, Po‐Jung, Min‐Hsien Wu, Hung‐Ming Wang, et al.. (2016). Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy. Scientific Reports. 6(1). 31423–31423. 35 indexed citations
8.
Chuang, Wen‐Yu, Yu‐Sun Chang, Yin‐Kai Chao, et al.. (2015). High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.. PubMed. 8(8). 9248–55. 10 indexed citations
9.
Chuang, Wen‐Yu, Yu‐Sun Chang, Yin‐Kai Chao, et al.. (2015). Phosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma.. PubMed. 8(10). 12757–65. 9 indexed citations
10.
Chao, Yin‐Kai, Wen‐Yu Chuang, Yu‐Wen Wen, et al.. (2015). Correlation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy. Medicine. 94(34). e1407–e1407. 19 indexed citations
11.
Chao, Yin‐Kai, Chi‐Ju Yeh, Yu‐Wen Wen, et al.. (2015). Factors Associated With False-Negative Endoscopic Biopsy Results After Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma. Medicine. 94(8). e588–e588. 9 indexed citations
12.
Chuang, Wen‐Yu, Chi‐Ju Yeh, Yin‐Kai Chao, et al.. (2014). Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.. PubMed. 7(8). 4847–56. 11 indexed citations
13.
Jaing, Tang‐Her, Chwei‐Chin Chuang, Shih‐Ming Jung, et al.. (2013). Malignant Triton Tumor of the Cervical Spine: Report of One Case and Review of the Literature. Pediatrics & Neonatology. 56(1). 58–61. 7 indexed citations
14.
Jaing, Tang‐Her, Iou‐Jih Hung, Chao‐Ping Yang, et al.. (2013). Malignant Renal Tumors in Childhood: Report of 54 Cases Treated at a Single Institution. Pediatrics & Neonatology. 55(3). 175–180. 6 indexed citations
15.
Yeh, Chi‐Ju, Wen‐Yu Chuang, Yin‐Kai Chao, et al.. (2010). High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(2). 171–178. 20 indexed citations
16.
Chuang, Wen‐Yu, Chi‐Ju Yeh, Yin‐Kai Chao, et al.. (2009). Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma.. PubMed. 24(8). 1021–7. 47 indexed citations
17.
Hsu, Peng‐Wei, et al.. (2007). Treatment of Epileptogenic Cavernomas: Surgery versus Radiosurgery. Cerebrovascular Diseases. 24(1). 116–120. 28 indexed citations
18.
19.
Tang, Simon G., Chen‐Kan Tseng, Pei‐Kwei Tsay, et al.. (2005). Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer. Journal of Neuro-Oncology. 73(2). 153–161. 10 indexed citations
20.
Chuang, Chi‐Cheng, Chen-Nen Chang, Ngan‐Ming Tsang, et al.. (2004). Linear Accelerator-Based Radiosurgery in the Management of Skull Base Meningiomas. Journal of Neuro-Oncology. 66(1-2). 241–249. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoto Shikama Breakdown of academic impact, for papers by Pramod Kumar Julka Breakdown of academic impact, for papers by Ferah Yıldız Breakdown of academic impact, for papers by Enis Özyar Breakdown of academic impact, for papers by Yavuz Anacak Breakdown of academic impact, for papers by H. Marsiglia Breakdown of academic impact, for papers by Robert H. Sagerman Breakdown of academic impact, for papers by Supriya Mallick Breakdown of academic impact, for papers by Giampaolo Biti Breakdown of academic impact, for papers by Gökhan Özyiğit
Rankless by CCL
2026